Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified
Conditions
Interventions
None listed
Sponsors
Narwade Pallavi Ashok
Eligibility
Inclusion criteria
Inclusion criteria: Patients complaining of excessive bleeding more than 80ml and Increased duration of bleeding more than 7 days as a cardinal symptom.
Exclusion criteria
Exclusion criteria: Use of IUCD Patient with ongoing treatment of systemic disease like diabetes, hypertension. Uterine and pelvic pathology like polyps, fibroids, adenomyosis Endocrinal disease (Hypo/Hyperthyroidism) Non- Menstrual causes for bleeding (foreign body, genital malignancy, abortion, post-coital) Pregnancy Hb less than 9gm/dl PCOS Post – menopausal bleeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in Bleeding Volume: Measure the average reduction in bleeding volume (ml) per episode after the intervention or treatment, aiming to bring the bleeding volume below 80 ml.Timepoint: 90 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of Bleeding: Measure the reduction in the duration of bleeding (hours or days) after the intervention, aiming to normalize the bleeding duration.Incidence of Excessive Bleeding: The proportion of participants who experience excessive bleeding (80 ml) after the intervention, compared to baseline.Hemoglobin Levels: Changes in hemoglobin levels before & after treatment, as excessive bleeding might lead to anemia.Quality of Life (QoL): Assess the impact of treatment on participants quality of life, including factors like pain, fatigue, & emotional well-being, possibly using a validated QoL questionnaire.Adverse Events: Incidence & severity of any adverse events related to the treatment or intervention used in the studyTimepoint: 90 days | — |
Countries
India
Contacts
Public ContactNarwade Pallavi Ashok
Sri Jayendra Saraswathi Ayurveda College and Hospital, Chennai
Outcome results
None listed